LATEST NEWS
Metabolomic Analysis May Predict Methotrexate Response in Rheumatoid Arthritis
Blunted Cortisol Responses May Be a Biomarker for Insomnia Risk
Heavy Alcohol Consumption Tied to Tobacco Use, Mediated by Marijuana Use
App Aids Self-Monitoring of Some Patients With Rheumatoid Arthritis
How Will New Federal Legislation Reduce Drug Costs?
Poliovirus Discovered in New York City Wastewater
FDA: Three At-Home COVID-19 Tests Needed to Confirm Negative Result
Social Networking Does Not Affect Health Outcomes in Rheumatoid Arthritis
Fear, Falls Unrelated to Pain Level, Catastrophizing in Knee Osteoarthritis
Vitamin D, Parathyroid Hormone Linked With Bone Decline in Older Men
Concomitant Opioid and Benzodiazepine Use at the ED May Have Long-Term Negative Health Impacts
LATEST FEATURES
Pulmonary Fibrosis Patient Registry Data Reveals Outcome Variations
Research based on Pulmonary Fibrosis Foundation Patient Registry data highlight potential disparities in the diagnosis, prognosis, and management of PF and ILD.
Digital Divide May Contribute to Telehealth Disparities
Access to internet-connected devices with cameras and skill in using digital platforms present barriers to a large portion of the population.
Ransomware Attacks, HIPAA Breaches Rise Sharply
Ransomware attacks now account for 25% of all data breaches, according to Verizon’s 2022 Data Breach Investigation Report.
Link Established Between Endogenous Retroviruses and Systemic Lupus Erythematosus
Akiko Iwasaki, PhD, discusses findings of a study she conducted that established a link between endogenous retroviruses and systemic lupus erythematosus.
OPINIONS
All the Guidelines in the World Can’t Eliminate Gray Areas
Jim Anderson, MPAS, PA-C, explores the role and limits of guidelines. He notes: Whether these practice aids are considered friends or foes, they can never eliminate the inevitable gray areas.
Defining “Disease Modification” in SLE: A Step Toward Improving Outcomes
An immunologist proposes a standard definition for “disease modification” in systemic lupus erythematosus to establish treatment targets in clinical trials and clinical practice.
Why Connections Between Immune-Mediated Diseases and Therapeutic Areas Matter
Lloyd S. Miller, MD, PhD, writes about understanding the overlapping immune pathways between psoriasis and psoriatic arthritis that may be useful to develop treatment plans for patients with these conditions.
Changing the Standard of Care: The Case for Combining Pegloticase With Immunomodulatory Agents in Gout
John Botson, MD, provides his perspective on including immunodulatory therapy in combination with pegloticase and encourages clinicians to evolve their standard of care in the treatment of uncontrolled gout.
COVID-19 Fatigue: Is It Over Yet?
Jim Anderson, MPAS, PA-C, explores COVID-19 fatigue and how it is all a bit numbing for medical providers who are trying to do their best to treat patients while clinging to trusted sources to help guide the way.
PODCASTS
Gout Among Women: Not Just a “Man’s Disease”
It’s Time We Took Chronic Pain in Rheumatology Seriously
The Elephant in the Rheum – “Burnout” Among the Workforce
In Rare We Care: Pediatric Rheumatic Disease Awareness & Management
Patient Care at the Intersection of Rheumatology and Neurology
CASE STUDIES
Case Study: ANCA-negative Small Vessel Vasculitis
Case study of a 70-year-old man who presents with vague signs of a rheumatic disease.
Case Study: COVID-19 and Cardiogenic Shock
The authors describe how to diagnose and treat comorbid cardiogenic shock and COVID-19 in this case study.
Case Study: Rheumatic Disease Presents With Rare Cardiac Manifestation
Case study of a woman with a rare cardiac manifestation of a rheumatic disease.
Case Study: Inflammatory Disease Presenting as a Doughnut Sign
Case study of a 37-year-old woman with a unique presentation of an inflammatory disease.
Case Study: Systemic Lupus Erythematosus With Lupus Nephritis and Thrombotic Microangiopathy
A 19-year-old woman presents with complaints of progressive shortness of breath, chest pain, and lower extremity edema over the past month.
- Loading...
Loading...
Loading... 
Loading...